Summit Therapeutics, Inc. (SMMT)
17.54
+0.05
(+0.29%)
USD |
NASDAQ |
Jan 02, 16:00
17.54
0.00 (0.00%)
After-Hours: 18:55
Summit Therapeutics EPS Diluted (Quarterly): -0.3118 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -5.079 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Arrowhead Pharmaceuticals, Inc. | -0.175 |
| Insmed, Inc. | -1.747 |
| CorMedix, Inc. | 1.259 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -231.79M |
| Total Expenses (Quarterly) | 231.79M |
| Enterprise Value | 12.79B |
| Earnings Yield | -7.08% |
| Normalized Earnings Yield | -7.080 |